IRIS UniCatt

Lombardi, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.232
EU - Europa 2.448
AS - Asia 2.327
SA - Sud America 503
Continente sconosciuto - Info sul continente non disponibili 126
AF - Africa 67
OC - Oceania 8
Totale 9.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.084
SG - Singapore 1.122
DE - Germania 513
CN - Cina 473
BR - Brasile 409
SE - Svezia 377
NL - Olanda 364
IT - Italia 361
FR - Francia 231
VN - Vietnam 180
PL - Polonia 147
IE - Irlanda 103
IN - India 103
GB - Regno Unito 97
BD - Bangladesh 86
FI - Finlandia 84
JP - Giappone 75
ID - Indonesia 73
CA - Canada 72
HK - Hong Kong 49
RU - Federazione Russa 40
MX - Messico 34
AR - Argentina 33
ES - Italia 26
BE - Belgio 23
IQ - Iraq 18
PK - Pakistan 17
TR - Turchia 17
UA - Ucraina 17
ZA - Sudafrica 17
EC - Ecuador 16
KR - Corea 16
LT - Lituania 12
VE - Venezuela 12
AT - Austria 11
CH - Svizzera 11
CI - Costa d'Avorio 10
CO - Colombia 10
IR - Iran 10
MA - Marocco 10
JO - Giordania 9
JM - Giamaica 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
KE - Kenya 7
MY - Malesia 7
EG - Egitto 6
OM - Oman 6
PY - Paraguay 6
SA - Arabia Saudita 6
CR - Costa Rica 5
CZ - Repubblica Ceca 5
IL - Israele 5
KZ - Kazakistan 5
LB - Libano 5
PA - Panama 5
SY - Repubblica araba siriana 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AL - Albania 4
AU - Australia 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PE - Perù 4
PR - Porto Rico 4
TN - Tunisia 4
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
DZ - Algeria 3
KG - Kirghizistan 3
LV - Lettonia 3
MD - Moldavia 3
NI - Nicaragua 3
NP - Nepal 3
QA - Qatar 3
DK - Danimarca 2
EU - Europa 2
GT - Guatemala 2
HR - Croazia 2
PH - Filippine 2
PS - Palestinian Territory 2
RO - Romania 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
Totale 9.574
Salva come PNG Salva come JPEG
Città #
Singapore 660
Chandler 486
Ashburn 403
Amsterdam 358
San Jose 332
New York 172
Los Angeles 136
Warsaw 136
Beijing 114
Dublin 99
Milan 89
The Dalles 83
Council Bluffs 78
Tokyo 73
Rome 72
Ho Chi Minh City 65
Jakarta 64
Lauterbourg 63
San Mateo 55
Hefei 51
Helsinki 51
Boston 50
St Louis 48
Hanoi 47
Tukwila 47
Frankfurt am Main 43
Hong Kong 43
Marseille 42
Princeton 42
São Paulo 42
Santa Clara 39
Wilmington 36
Dallas 35
Atlanta 34
Jacksonville 32
Orem 32
Fairfield 27
Nuremberg 27
Ann Arbor 26
Brooklyn 26
Buffalo 26
Chicago 26
Houston 26
Moscow 26
London 25
Munich 24
Nanjing 24
Brussels 23
Phoenix 22
Seattle 21
Woodbridge 21
Denver 20
Paris 20
Turku 20
Montreal 19
Chennai 17
Pune 17
Toronto 17
Düsseldorf 16
Cambridge 15
Kent 14
Poplar 14
Seoul 14
Augusta 13
Cattolica 12
Redwood City 12
Dearborn 11
Guangzhou 11
Haiphong 11
San Francisco 11
Stockholm 11
Abidjan 10
Da Nang 10
Dhaka 10
Johannesburg 10
Mexico City 10
Amman 9
Hangzhou 9
Hyderabad 9
Lappeenranta 9
Mumbai 9
San Antonio 9
Boardman 8
Columbus 8
Lahore 8
Ottawa 8
Queens 8
Roubaix 8
Turin 8
Andover 7
Buenos Aires 7
Curitiba 7
Guayaquil 7
Nanchang 7
North Bergen 7
Philadelphia 7
Rio de Janeiro 7
Tianjin 7
Vienna 7
Belo Horizonte 6
Totale 5.153
Salva come PNG Salva come JPEG
Nome #
Functional associations between polymorphic regions of the human 3'IgH locus and COVID-19 disease 861
Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene 354
Psychological distress during the initial stage of the COVID-19 pandemic in an italian population living with HIV: An online survey 317
Use of Long-Acting Therapies for HIV Care in Italy: Are People Living with HIV Prepared for Change? A Cross-Sectional Study 305
Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV 303
The association between stigma and wellbeing in an Italian cohort of PLWH: The role of social support and personal factors 287
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 209
Sarilumab use in severe SARS-CoV-2 pneumonia 179
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine versus the 23-valent polysaccharide vaccine in unvaccinated HIV-infected adults: A pilot, prospective controlled study 172
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 162
HIV DNA Decay in a Treatment-Naive Patient Starting Dolutegravir Plus Lamivudine with Resistance Mutations to Integrase Inhibitors: A Case Report 162
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 157
Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study 153
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV 152
Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database 148
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 148
Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice 147
Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failure 145
Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: A retrospective study from the clinical practice 144
HIV-1 non-R5 tropism correlates with a larger size of the cellular viral reservoir and a detectable residual viremia in patients under suppressive ART 143
Factors Associated with Low-Level Viremia in People Living with HIV in the Italian Antiviral Response Cohort Analysis Cohort: A Case-Control Study 143
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 142
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 141
Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults 138
An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, Italy 137
Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical Practice 133
Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line 132
Seroprevalence of sars-cov-2 antibodies in hiv-infected patients in rome, italy during the covid-19 outbreak 131
Impact of pre-existent drug resistance on virological efficacy of single-tablet regimens in people living with HIV 130
Trends of hospitalisations rates in a cohort of HIV-infected persons followed in an Italian hospital from 1998 to 2016 130
Dynamics of total and intact HIV-1 DNA in virologically suppressed patients switching to DTG- or ATV-based dual therapy 127
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study 124
Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen 122
Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication 122
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed 120
Home Care Assistance: Has Covid-19 had an Impact on the Complex Management of HIV Patients? 120
Pretreatment HIV drug resistance and treatment failure in non-Italian HIV-1-infected patients enrolled in ARCA 120
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian Hospital 120
Letter to the Editor: Real-Life Experience of Long-Acting Cabotegravir-Rilpivirine Combination in a Person Living with HIV with Detectable Viremia: A Case Report 115
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study 114
Quantification of total hiv dna as a marker to measure viral reservoir: Methods and potential implications for clinical practice 113
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy 113
Evaluation of doravirine-based regimen population target in a large Italian clinical center 111
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy 110
Clinical presentation of human monkeypox virus infection during the 2022 outbreak: descriptive case series from a large italian Research Hospital 110
Reduced soluble CD14 levels after switching from a dual regimen with lamivudine plus boosted protease inhibitors to lamivudine plus dolutegravir in virologically suppressed HIV-infected patients 109
Response to BNT162b2 mRNA COVID-19 vaccine of ART-experienced people living with HIV: a prospective analysis from a single-center study in Rome, Italy 107
Characteristics of mental health interventions in a cohort of Italian PLWH over the last five years: impact of HIV disease and outbreak of COVID-19 pandemic 106
Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections 105
Real World Data from an Italian Outpatient Clinical Setting and from Home Care Assistance of Treatment-Experienced PWH Switching to CAB + RPV Regimen: A Prospective Observational Study 102
Real-Life Safety of Doravirine in Treatment-Experienced, Virologically Suppressed PLWHIV 102
Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors 100
No evidence of SARS-CoV-2 circulation in HIV-infected patients between December 2019 and February 2020 in Rome, Italy 99
Assessing dengue seroprevalence among people living with HIV (PLWH) in rome, Italy: Insights from the 2023 Italian autochthonous outbreak 98
Nasopharingeal bacterial and fungal colonization in HIV-positive versus HIV-negative adults 98
Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life setting 97
Short Communication: Efficacy and Safety of Dolutegravir plus Lamivudine as a First-Line Regimen in Clinical Practice 93
Long-term maintenance of virologic suppression in native and migrant HIV-1 naïve patients: an Italian cohort study 90
A Conserved Glycan in the C2 Domain of HIV-1 Envelope Acts as a Molecular Switch to Control X4 Utilization by Clonal Variants with Identical V3 Loops 90
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 88
Impact of resistance mutations on efficacy of dolutegravir plus rilpivirine or plus lamivudine as maintenance regimens: a cohort study 85
Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection 83
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference 81
Compound heterozygosity for mutations in LMNA in a patient with a myopathic and lipodystrophic mandibuloacral dysplasia type A phenotype 79
Comparison of HIV-DNA decay in naive patients starting dolutegravir plus lamivudine or dolutegravir-based triple therapy 66
Increased release and activity of matrix metalloproteinase-9 in patients with mandibuloacral dysplasia type A, a rare premature ageing syndrome 52
‘Leaving no stones unturned’: up to 10 years results on the effectiveness, tolerability and metabolic safety of dolutegravir+lamivudine (DTG+3TC) as a switch regimen in the ODOACRE cohort 8
Machine Learning-Guided Hypotension Prediction and Goal-Directed Therapy During Transcatheter Valve Repair: A Prospective Observational Study 7
Totale 9.711
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.859
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.859
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022458 0 0 0 52 11 7 38 78 14 44 60 154
2022/20231.220 168 187 97 181 75 143 66 94 137 8 52 12
2023/2024684 16 147 17 65 26 138 47 15 18 28 97 70
2024/20251.350 23 18 161 54 103 71 97 74 161 120 256 212
2025/20264.136 468 92 186 475 673 817 542 161 212 239 154 117
2026/20271.260 169 766 171 154 0 0 0 0 0 0 0 0
Totale 9.711